Discovery of a potent STAT3 inhibitor WR-S-647 for the treatment of ADPKD

Key Points

• WR-S-647 effectively inhibits STAT3, leading to significant effects on ADPKD pathology.
• The study observes a reduction in cyst growth and kidney function decline.
• Assessment using cellular and animal models demonstrates promising therapeutic potential for WR-S-647.
• Findings support the consideration of STAT3 inhibition as a viable treatment strategy for ADPKD.